Previous Article | Next Article ![]()
Infect. Immun., 12 1996, 5171-5177, Vol 64, No. 12
JA Triccas, PW Roche, N Winter, CG Feng, CR Butlin and WJ Britton
The control of leprosy will be facilitated by the identification of major
Mycobacterium leprae-specific antigens which mirror the immune response to
the organism across the leprosy spectrum. We have investigated the host
response to a 35-kDa protein of M. leprae. Recombinant 35-kDa protein
purified from Mycobacterium smegmatis resembled the native antigen in the
formation of multimeric complexes and binding by monoclonal antibodies and
sera from leprosy patients. These properties were not shared by two forms
of 35-kDa protein purified from Escherichia coli. The M. smegmatis-derived
35-kDa protein stimulated a gamma interferon-secreting T-cell proliferative
response in the majority of paucibacillary leprosy patients and healthy
contacts of leprosy patients tested. Cellular responses to the protein in
patients with multibacillary leprosy were weak or absent, consistent with
hyporesponsiveness to M. leprae characteristic of this form of the disease.
Almost all leprosy patients and contacts recognized the 35-kDa protein by
either a T-cell proliferative or an immunoglobulin G antibody response,
whereas few tuberculosis patients recognized the antigen. This specificity
was confirmed in guinea pigs, with the 35-kDa protein eliciting strong
delayed-type hypersensitivity in M. leprae- sensitized animals but not in
those sensitized with Mycobacterium tuberculosis or Mycobacterium bovis
BCG. Therefore, the M. leprae 35- kDa protein appears to be a major and
relatively specific target of the human immune response to M. leprae and is
a potential component of a diagnostic test to detect exposure to leprosy or
a vaccine to combat the disease.
Copyright © 1996, American Society for Microbiology
A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae
Centenary Institute of Cancer Medicine and Cell Biology, Newtown, New South Wales, Australia.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|